Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20190121042444N5
IRCT20190121042444N5RecruitingPhase 3

Comparison of the effects of two drugs, propofol and isoflurane, as anesthetic agents on gene expression mt-DNA in posterior vertebral fixation surgeries

Shahid Beheshti University of Medical Sciences0 sites34 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
34
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 70 years (—)
Sex
All

Inclusion Criteria

  • •Patients who are candidates for elective surgery for posterior stabilization of the lumbar spine
  • •ASA class I-II

Exclusion Criteria

  • •Previous history of surgery
  • •ASA class III or higher
  • •Malignancies
  • •Cardiovascular diseases
  • •Chronic inflammatory diseases
  • •Corticosteroid use
  • •Emergency surgery
  • •Any instability of the patient during surgery
  • •Drug addiction

Investigators

Similar Trials

Recruiting
Phase 3
Effect of two drugs, propofol and fentanyl in controlling emergence agitation following anesthesia with sevoflurane gasagitation due to sevoflurane gas.Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
IRCT20181130041804N1Sanandaj University of Medical Sciences50
Completed
Phase 4
It is a study to compare the effectiveness of two anaesthesia techniques in reducing postoperative nausea and vomiting in female patients undergoing laparoscopic surgery using propofol in one and combination of propofol and sevoflurane as maintenance agents in another
CTRI/2019/09/021449Department of anaesthesiology70
Not yet recruiting
Not Applicable
A clinical trial to study the effects of two drugs, propofol and etomidate on blood pressure, seizure duration, and recovery profile during electro - convulsive therapy.
CTRI/2019/03/018031SVIMS University
Not yet recruiting
Phase 4
Studying effect of propofol and ketamine as induction agents in electro convulsive therapy in patients with depression.
CTRI/2024/03/064547Kapuri Manasa
Not yet recruiting
Not Applicable
Comparison between propofol and dexamethasone for preventing postoperative nausea and vomiting after ENT surgeries.
CTRI/2022/10/046220Dr sathvika Pati